Scientific Publications
Featured Publications
Usage Report:
Comparative Study:
Other Publications
- Weiser B., Genzling J., Burai-Patrascu M., Rostaing O., Moitessier, N. Machine Learning-Augmented Docking. 1. CYP inhibition prediction. Drug Discovery (2023), Advance Article
- Wei, W., Luo, J., Waldispühl, J., Moitessier, N. Predicting Positions of Bridging Water Molecules in Nucleic Acid–Ligand Complexes. Journal of Chemical Information and Modeling (2019), 59 (6), 2941-2951
- Pottel, J., Moitessier, N. Customizable Generation of Synthetically Accessible, Local Chemical Subspaces. Journal of Chemical Information and Modeling (2017), 57, 454-467
- Moitessier N., Pottel J., Therrien E., Englebienne P., Liu Z., Tomberg A., Corbeil C.R. Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods. Accounts of Chemical Research (2016), 49 (9), 1646-1657
- Pottel J., Moitessier N. Single-Point Mutation with a Rotamer Library Toolkit: Toward Protein Engineering. Journal of Chemical Information and Modeling (2015), 55, 12, 2657-2671
- Pottel J., Therrien E., Gleason J.L., Moitessier N. Docking Ligands into Flexible and Solvated Macromolecules. 6. Development and Application to the Docking of HDACs and other Zinc Metalloenzymes Inhibitors. Journal of Chemical Information and Modeling (2014), 54, 254-265
- Campagna-Slater V., Pottel J., Therrien E., Cantin L.-D., Moitessier N. Development of a computational tool to rival experts in the prediction of sites of metabolism of xenobiotics by P450s. Journal of Chemical Information and Modeling (2012), 52, 2471-2483
- Therrien E., Englebienne P., Arrowsmith A.G., Mendoza-Sanchez R., Corbeil C.R., Weill N., Campagna-Slater V., Moitessier N. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with FORECASTER, a novel platform for drug discovery. Journal of Chemical Information and Modeling (2012), 52, 210-224
- Weill N., Corbeil C.R., De Schutter J.W., Moitessier N. Toward a computational tool predicting the stereochemical outcome of asymmetric reactions: Development of the molecular mechanics-based program ACE and application to asymmetric epoxidation reactions. Journal of Computational Chemistry (2011), 32, 2878-2889
- Englebienne P., Moitessier N. Docking ligands into flexible and solvated macromolecules. 5. Force-field-based prediction of binding affinities of ligands to proteins. Journal of Chemical Information and Modeling (2009), 49, 2564-2571
- Englebienne P., Moitessier N. Docking ligands into flexible and solvated macromolecules. 4. Are popular scoring functions accurate for this class of proteins? Journal of Chemical Information and Modeling (2009), 49, 1568-1580
- Corbeil C.R., Moitessier N. Docking ligands into flexible and solvated macromolecules. 3. Impact of input ligand conformation, protein flexibility, and water molecules on the accuracy of docking programs. Journal of Chemical Information and Modeling (2009), 49, 997-1009
- Fay A.-M.L., Corbeil C.R., Brown P., Moitessier N., Bowie D. Functional characterization and in silico docking of full and partial GluK2 kainate receptor agonists. Molecular Pharmacology (2009), 75, 1096-1107
- Corbeil C.R., Englebienne P., Yannopoulos C.G., Chan L., Das S.K., Bilimoria D., L’Heureux L., Moitessier N. Docking ligands into flexible and solvated macromolecules. 2. Development and application of FITTED 1.5 to the virtual screening of potential HCV polymerase inhibitors. Journal of Chemical Information and Modeling (2008), 48, 902-909
- Corbeil C.R., Thielges S., Schwartzentruber J.A., Moitessier N. Toward a computational tool predicting the stereochemical outcome of asymmetric reactions: Development and application of a rapid and accurate program based on organic principles. JAngewandte Chemie – International Edition (2008), 47, 2635-2638
- Corbeil C.R., Englebienne P., Moitessier N. Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0. Journal of Chemical Information and Modeling (2007), 47, 435-449
User reports, reviews, and comparative studies:
- Ramos, A., et al. Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds. Journal of Medicinal Chemistry (2024), 67, 8, 6456-6494.
- Breinlinger, E., et al. Targeting the Tyrosine Kinase 2 (TYK2) Pseudokinase Domain: Discovery of the Selective TYK2 Inhibitor ABBV-712 Journal of Medicinal Chemistry (2023), 66, 20, 14335-14356.
- Nemes, B., et al. Elucidation of the binding mode of organic polysulfides on the human TRPA1 receptor Frontiers in Physiology (2023)
- Mesmar, F., et al. The herbicide acetochlor causes lipid peroxidation by inhibition of glutathione peroxidase 4 BioRxiv (2023)
- Ferguson, T. E. G., et al. Novel inhibitiors and activity-based probes targeting serine proteases Frontiers in Chemistry (2022)
- Alhayek, A., et al. Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin-Wound Infections. Advanced Therapeutics (2022)
- Refaay, D.A., Ahmed, D.M., Mowafy, M.A., Shaaban, S. Evaluation of novel multifunctional organoselenium compounds as potential cholinesterase inhibitors against Alzheimer’s disease. Medicinal Chemistry Research (2022)
- Zoltán Zsidó, B., et al. Prerequisite Binding Modes Determine the Dynamics of Action of Covalent Agonists of Ion Channel TRPA1. Pharmaceuticals (2021).
- Zhou, Y., Jiang, Y., Chen, S-J. RNA–ligand molecular docking: Advances and challenges. WIREs Computational Molecular Science (2021), e1571
- Bailey, J. J., Wuest, M., Bojovic, T., Kronemann, T., Wängler, C., Wängler, B., Wuest, F., Schirrmacher, R. On the Viability of Tadalafil-Based 18F-Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging. ACS Omega (2021), ASAP
- Souza, A.L.P.F., Cardoso, F.J.B., Martins, L.S., Alves, C.N., Silva, J.R.A., Molfetta, F.A. Molecular Modelling Study of Heteroarylamide/Sulfonamide Compounds with Antitrypanosomal Activity. Journal of Brazilian Chemical Society (2021), 32, 1, 83-97
- Scarpino, A., Ferenczy, G.G., Keserü, G.M. Covalent Docking in Drug Discovery: Scope and Limitations. Current Pharmaceutical Design (2020), 26, 44, 5684-5699
- Caballero, J. The latest automated docking technologies for novel drug discovery. Expert Opinion on Drug Discovery (2020)
- Majewski, M.W., et al. Synthesis and Initial Pharmacology of Dual-Targeting Ligands for Putative Complexes of Integrin αVβ3 and PAR2. RSC Medicinal Chemistry (2020), 11, 940-949
- Stille, J., Tjutrins, J., Wang, G., Venegas, F.A., Hennecker, C., Rueda, A.M., Miron, C.E., Labarre, A., Plescia, J., Burai Patrascu, M., Vlaho, D., Huot, M., Mittermaier, A.K., Moitessier, N. Design, Synthesis and Biological Evaluation of Novel SARS-CoV-2 3CLpro Covalent Inhibitors. European Journal of Medicinal Chemistry (2020)
- Foscato, M., Jensen, V.R. Automated in Silico Design of Homogeneous Catalysts. ACS Catalysis (2020), 10, 3, 2354-2377
- Plescia, J., Dufresne, C., Janmamode, N., Wahba, A.S., Mittermaier, A.K., Moitessier, N. Discovery of covalent prolyl oligopeptidase boronic ester inhibitors. European Journal of Medicinal Chemistry (2020), 185, 111783
- Bernard-Gauthier, V., Mossine, A.V., Knight, A., Patnaik, D., Zhao, W-N., Cheng, C., Krishnan, H., Xuan, L.L., Chindavong, P.S., Reis, S.A., Chen, J.M., Shao, X., Stauff, J., Artaega, J., Sherman, P., Salem, N., Bonsall, D., Amaral, B., Varlow, C., Well, L., Martarello, L., Patel, S., Liang, S.H., Kurumbail, R.G., Haggarty, S.J., Scott, P.J.H., Vasdev, N. Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery. Journal of Medicinal Chemistry (2019), 62, 21, 9600-9617
- Reinecke, M., Ruprecht, B., Poser, S., Wiechmann, S., Wilhelm, M., Heinzlmeir, S., Kuster, B., Médard, G. Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors. ACS Chemical Biology (2019), 14, 4, 655-664
- Plescia, J., De Cesco, S., Burai Patrascu, M., Kurian, J., Di Trani, J. M., Dufresne, C., Wahba, A., Janmamode, N., Mittermaier, A. K., Moitessier, N., Integrated synthetic, biophysical and computational investigations of covalent inhibitors of prolyl oligopeptidase and fibroblast activation protein α .Journal of Medicinal Chemistry (2019), 62, 7874-7884
- Burkett, D. J., Wyatt, B. N., Mews, M., Bautista, A., Engel, R., Dockendorff, C., Donaldson, W. A., St. Maurice, M. Evaluation of α-hydroxycinnamic acids as pyruvate carboxylase inhibitors. Bioorganic & Medicinal Chemistry (2019), 27, 4041-4047
- Yang, Z., Shen, M., Tang, M., Zhang, W., Cui, X., Zhang, Z., Pei, H., Li, Y., Hu, M., Bai, P., Chen, L. Discovery of 1,2,4-oxadiazole-containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy. European Journal of Medicinal Chemistry (2019), 178, 116-130
- Scarpino, A., Ferenczy, G.G., Keserü, G.M. Comparative Evaluation of Covalent Docking Tools. Journal of Chemical Information and Modeling (2018), 58, 7, 1441-1458
- Sotriffer, C. Docking of Covalent Ligands: Challenges and Approaches. Molecular Informatics (2018), 37, 1800062
- Wu, Y., Dockendorff, C. Synthesis of a novel bicyclic scaffold inspired by the antifungal natural product sordarin. Tetrahedron Letters (2018), 59, 3373-3376
- Chen, Y., Wang, X., Xiang, W., He, L., Tang, M., Wang, F., Wang, T., Yang, Z., Yi, Y., Wang, H., Niu, T., Zheng, L., Lei, L., Li, X., Song, H., Chen, L. Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities. Journal of Medicinal Chemistry (2016), 59, 5488-5504
- Bernard-Gauthier, V., Aliaga, A., Boudjemeline, M., Hopewell, R., Kostikov, A., Rosa-Neto, P., Thiel, A., Schirrmacher, R. Syntheses and Evaluation of Carbon-11- and Fluorine-18-Radiolabeled pan-Tropomyosin Receptor Kinase (Trk) Inhibitors: Exploration of the 4-Aza-2-oxindole Scaffold as Trk PET Imaging Agents. ACS Chemical Neuroscience (2015), 6, 260-276
- Schiavini, P., Cheong K.J., Moitessier N., Auclair K. Active site crowding of P450 3A4 as a strategy to alter its selectivity. ChemBioChem (2017), 18, 248-252
- McCracken et al. Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia (2017),
- Mariaule G., De Cesco S., Airaghi F., Kurian J., Schiavini P., Rocheleau S., Huskić I., Auclair K., Mittermaier A., Moitessier N. 3-Oxo-hexahydro-1H-isoindole-4-carboxylic acid as a Drug Chiral Bicyclic Scaffold: Structure-based Design and Preparation of Conformationally Constrained Covalent and Non-Covalent Prolyl Oligopeptidase Inhibitors. Journal of Medicinal Chemistry (2016), 59 (9), 4221-4234
- Schiavini P., Pottel J., Moitessier N., Auclair K. Metabolic Instability of Cyanothiazolidine-Based Prolyl Oligopeptidase Inhibitors: a Structural Assignment Challenge and Potential Medicinal Chemistry Implications. ChemMedChem (2015), 10, 1174-1183
- Schiavini P., Dawe B., Bowie D., Moitessier N. Discovery of novel small-molecule antagonists for GluK2. Bioorganic & Medicinal Chemistry Letters (2015), 25, 2416-2420
- Mendoza-Sanchez R., Cotnoir-White D., Kulpa J., Jutras I., Pottel J., Moitessier N., Mader S., Gleason J. L. Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids. Bioorganic & Medicinal Chemistry Letters (2015), 23, 7597-7606
- Agostino, M., Gandhi, N. S., Mancera, R. L. Development and application of site mapping methods for the design of glycosaminoglycans. Bioorganic & Glycobiology (2014), 24, 840-851
- Therrien E., Weill N., Tomberg A., Corbeil C.R., Lee D., Moitessier N. Docking Ligands into Flexible and Solvated Macromolecules. 7. Impact of Protein Flexibility and Water Molecules on Docking-Based Virtual Screening Accuracy. Journal of Chemical Information and Modeling (2014), 54, 3198-3210
- De Cesco S., Deslandes S., Therrien E., Levan D., Cueto M., Schmidt R., Cantin L.-D., Mittermaier A., Juillerat-Jeanneret L., Moitessier N. Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells. Journal of Medicinal Chemistry (2012), 55, 6306-6315
- Castor K.J., Mancini J., Fakhoury J., Weill N., Kieltyka R., Englebienne P., Avakyan N., Mittermaier A., Autexier C., Moitessier N., Sleiman H.F. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes. ChemMedChem (2012), 7, 85-94
- Lamblin M., Spingarn R., Wang T.-T., Burger M.C., Dabbas B., Moitessier N., White J.H., Gleason J.L. An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D-3 functions as a strong vitamin D receptor antagonist. Journal of Medicinal Chemistry (2010), 53, 7461-7465
- Corbeil C.R., Moitessier N. Theory and application of medium to high throughput prediction method techniques for asymmetric catalyst design. Journal of Molecular Catalysis A: Chemical (2010), 324, 146-155
- Corbeil C.R., Therrien E., Moitessier N. Modeling reality for optimal docking of small molecules to biological targets. Current Computer-Aided Drug Design (2009), 5, 241-263
- Lawandi J., Toumieux S., Seyer V., Campbell P., Thielges S., Juillerat-Jeanneret L., Moitessier N. Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors. Journal of Medicinal Chemistry (2009), 52, 6672-6684
- Moitessier N., Englebienne P., Lee D., Lawandi J., Corbeil C.R. Towards the development of universal, fast and highly accurate docking/scoring methods: A long way to go. British Journal of Pharmacology (2008), 153, SUPPL. 1, S7-S26